Leukotriene modifiers: what is their position in asthma therapy?
- PMID: 9723656
- DOI: 10.1016/s0091-6749(98)70081-8
Leukotriene modifiers: what is their position in asthma therapy?
Comment on
-
Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.J Allergy Clin Immunol. 1998 Aug;102(2):177-83. doi: 10.1016/s0091-6749(98)70083-1. J Allergy Clin Immunol. 1998. PMID: 9723658 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
